Collabrx, Inc.
Records under this name other than patents Collabrx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Collabrx, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,262,103 | Individualized Cancer Treatment now held by Genekey Corporation In force · High confidence | In force | High confidence | |
| US 7,153,542 | Assembly Line Processing Method now held by Lam Research Corporation Term ended Term ended May 29, 2023 · High confidence | Term ended | Term ended May 29, 2023 | High confidence |
| US 6,921,555 | Method and system for sequential processing in a two-compartment chamber now held by Lam Research Corporation Term ended Term ended Oct 20, 2022 · High confidence | Term ended | Term ended Oct 20, 2022 | High confidence |
| US 6,858,085 | Two-Compartment Chamber for Sequential Processing now held by Lam Research Corporation Term ended Term ended Aug 6, 2022 · High confidence | Term ended | Term ended Aug 6, 2022 | High confidence |
| US 8,426,418 | Method to Treat Melanoma in Braf Inhibitor-Resistant Subjects now held by Genekey Corporation Lapsed on the fee record Ended Apr 23, 2021 · High confidence | Lapsed on the fee record | Ended Apr 23, 2021 | High confidence |
| 14/730,228 | Actionability framework for genomic biomarker Abandoned Abandoned Aug 13, 2018 | Abandoned | Abandoned Aug 13, 2018 |